2Cox JD,Stetz J,Pajak TF.Toxicity criteria of the radiation therapy oncolo-gy group(RTOG)and the European organization for research and treat-ment of cancer(EORTC)[J].Int J Radiat Oncol Biol Phys,1995;31(5):1341-6.
6Liu HH,Wang X,Dong L,et al.Feasibility of sparing lung and other tho-racic structures with intensity-modulated radiotherapy for non-small-celllung cancer[J].Int J Radiat Oncol Biol Phys,2004;58(4):1268-79.
二级参考文献16
1Grills IS, Yah D, Martinez AA, et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation ,and elective nodal irradiation[J]. Int J Radiat Oncol Biol Phys,2003,57(3):875.
2Liu HH,Wang X,Dong L,et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys ,2004, 58(4):1268.
3Dancey J,Shepherd FA,Gralla RJ,et al. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective randomized phase Ⅲ trial[J]. Lung Cancer,2004,43:183.
4Fosella FV,DeVore R,Kerr RN,et al. Randomized phase Ⅲ trial of doeetaxel versus vineorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy reglmens[J]. J Clin Oncol,2000,18:2354.
5Pritchard R,,Anthony S.Chemotherapy plus radiotherapy com-pared with radiotherapy alone in the treatment of locally ad-vanced,unresectable,non-small-cell lung cancer[].Annals of Internal Medicine.1996
7Clamon G,Herndon J,Cooper R,et al.Radiosensitizationwith carboplation for patients with unresectable stageⅢnon-small lung cancer:A phaseⅢtrial of the Cancer and Leukemi-a Group B and the Eastem Cooperative Oncology Group[].JClin Onco.1999
8Gervais R,Ducolone A,Lechevalier T,et al.Conventionalvatiation(RT)with daily carboplatin(Cb)compared to RT a-lone after induction chemotherapy(ICT)[vinorelbine(Vr)-cis-platine(P)]:Final results of a randomized phaseⅢtrial instageⅢunresectable non-small cell lung cancer(NSCLC)[].Journal of Clinical Oncology.2005
9Furuse K,Fukuoka M,Kawahara M,et al.For the West Ja-pan Lung Cancer Group PhaseⅢstudy of concurrent versussequential thoracic radiotherapy in combination with mitomy-cin,vindesine,and cisplatin in unresectable stageⅢnon-smalllung cancer[].Journal of Clinical Oncology.1999
10Albain K,Rusch VW,Crowley JJet al.Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stageⅢa(N2)andⅢb non-small cell lung cancer:mature results ofSouthwest Oncology Group phaseⅡstudy8805[].Journal of Clinical Oncology.1995
5Gore E, Movsas B, Santana-Davila R, et al. Evaluation and management of elderly patients with lung cancer[J]. Semin Radiat Oncol, 2012,22(4) : 304-310.
6Choy H,Salran H,Akerley W,et al. Phasell trial of weekly paelitaxel and concurrent radiation therapy for locally advanced non-small cell lung Cancer[J]. Clin Cancer Res, 1998, 4(8) : 1931-1936.
